Samodzielny Publiczny Zaklad Opieki Zdrowotnej Centralny Szpital Kliniczny Uniwersytetu Medycznego W Lodzi
- Address
- ul. Sporna 36/50, 91-738 Lodz, Poland
Hematology and Oncology
At Samodzielny Publiczny Zaklad Opieki Zdrowotnej Centralny Szpital Kliniczny Uniwersytetu Medycznego W Lodzi, clinical research in hemic and lymphatic diseases and neoplasms focuses on childhood blood cancers and solid tumors. The main conditions studied include acute myeloid leukemia, myeloid leukemia in children with Down syndrome, and hepatoblastoma with other liver cancers, with trials aimed at improving treatment effectiveness, refining risk-based care, and reducing side effects.
- Testing new treatment approaches for acute myeloid leukemia in children and adolescents
- Evaluating better outcomes for myeloid leukemia in children with Down syndrome
- Studying more personalized care for hepatoblastoma and hepatocarcinoma
This work combines oncology with pediatric care, reflecting a strong focus on improving survival while limiting treatment burden in young patients.
Metabolic and Endocrine Research
The site also supports studies in nutritional and metabolic diseases, especially obesity and overweight in adolescents. These trials are designed to assess whether newer therapies can help improve weight control and related health problems, offering support for young people with metabolic risk factors.
- Assessing treatment options for obesity in adolescents with additional health risks
- Studying care strategies for overweight youth with weight-related comorbidities
Research in this area is centered on finding effective ways to manage excess weight early, before it leads to more serious long-term complications.
Pediatric Rheumatology and Musculoskeletal Care
Clinical trials in musculoskeletal diseases at this hospital/clinic include work on juvenile idiopathic arthritis and osteogenesis imperfecta. The goal is to evaluate therapies that may improve symptoms, protect bone health, and reduce the impact of chronic disease on daily life in children and adolescents.
- Exploring new options for juvenile idiopathic arthritis in children
- Comparing approaches to strengthen bone health in osteogenesis imperfecta
This research brings together pediatric rheumatology and bone health, with an emphasis on safer and more effective long-term care.
Congenital and Hereditary Disease Studies
The research portfolio also includes congenital, hereditary, and neonatal diseases and abnormalities, with attention to inherited disorders that affect growth, bone strength, and overall development. These trials aim to improve treatment planning, support individualized care, and better understand how to manage complex pediatric conditions.
- Investigating inherited conditions linked to bone fragility and developmental concerns
- Supporting more tailored treatment for children with genetic disease
The work reflects a pediatric specialty environment where rare and complex diseases are studied alongside more common chronic conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 therapeutic areas and 15 of 27 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1GPOH gGmbH2active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1GPOH gGmbH2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Samodzielny Publiczny Zaklad Opieki Zdrowotnej Centralny Szpital Kliniczny Uniwersytetu Medycznego W Lodzi
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Clinical Trial Evaluating Doxorubicin Hydrochloride, Fluorouracil, and Oxaliplatin in Pediatric Hepatoblastoma and Hepatocarcinoma Treatment | Medical University Of Gdansk | Phase III | Recruiting | Aug 2025 | — |
IMP list
lock Showing 1 of 27 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cytarabine | 2 | Unknown | 2022-12-06 | 2024-10-28 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.